Given these pro-resolving actions of ANXA1 in cerebrovascular disease, its reduction in the hippocampus of our HF-fed females could contribute to the worse vascular outcomes (lower CBF) and hippocampal-dependent cognitive deficits we previously observed. This evidence concerns the gene ANXA1 and cerebrovascular disorder.